The Joe Rogan ExperienceJoe Rogan Experience #2454 - Robert Malone, MD
CHAPTERS
- 0:02 – 1:23
Back after five years: fallout from Malone’s last appearance and what “came true”
Joe and Dr. Malone open by revisiting Malone’s controversial prior episode and the public/media backlash that followed. They frame this return as a chance to reflect on what was said then, how it was received, and what subsequent events validated or changed.
- •Five-year gap since Malone’s last JRE appearance
- •Attempts to label Malone as a “quack” despite his credentials
- •Rogan’s view that Malone’s warnings were later vindicated
- •Setting the stage for revisiting censorship and COVID-era narratives
- 1:23 – 3:27
Why Malone took the vaccine: early risk perception, travel pressure, and adverse events
Malone describes taking Moderna early in 2021 and experiencing multiple adverse reactions. He explains the combination of social pressure, travel restrictions, and his own uncertainty about whether technical problems had been solved.
- •Malone’s reported adverse events after vaccination
- •Medical peers questioning his decision to get vaccinated
- •Role of travel mandates and restrictions in his choice
- •Emotional climate of fear and anxiety during early COVID
- 3:27 – 7:31
mRNA delivery problems in the 80s–90s: inflammation, biodistribution, and formulation limits
Malone recounts early mRNA and lipid delivery research challenges: strong inflammation, inconsistent expression, and inability to keep the payload localized. He explains why these obstacles led many groups to abandon RNA delivery for long periods.
- •Inflammation signals in mice and monkey models
- •Difficulty localizing delivery to the injection site
- •Manufacturing complexity and unreliable reactions
- •Why earlier programs pivoted away from RNA delivery
- 7:31 – 11:35
The ‘magic sauce’ of lipid nanoparticles: UBC’s role, PEG ‘stealth’ design, and trust in experts
The conversation turns to lipid nanoparticle design and Malone’s claim that UBC researcher Pieter Cullis solved key delivery issues. Malone explains PEGylation concepts, how formulations were said to behave in the body, and why he trusted those assurances.
- •Claimed improvements: local retention and lymph node targeting
- •PEG as a ‘stealth liposome’ strategy and its intended behavior
- •Pieter Cullis/UBC licensing to BioNTech and Moderna
- •Malone’s decision-making: taking an expert’s word under pressure
- 11:35 – 19:04
Long COVID experience and early self-treatment: famotidine, quercetin, and repurposed-drug strategy
Malone describes getting COVID in Feb 2020 and persistent symptoms that he characterizes as long COVID. He outlines his early repurposed-drug work, including self-experimentation and the path that led him to prioritize existing medications over vaccine timelines.
- •Timeline: infection linked to Boston travel early in the pandemic
- •Long-term stamina and pulmonary-function issues
- •Self-experimentation with famotidine and other compounds
- •Strategic belief: repurposed drugs are faster than vaccines in outbreaks
- 19:04 – 22:39
Ivermectin, FDA resistance, and the ‘forbidden’ countermeasure narrative
Malone recounts attempts to build a DOD-supported adaptive trial combining famotidine, celecoxib, and ivermectin, which he says the FDA repeatedly rejected. Joe presses on why ivermectin was uniquely demonized compared with other treatments, leading into hypotheses about incentives and emergency authorizations.
- •DOD funding and proposed clinical trial design
- •FDA demands (e.g., cell culture proof) and trial redesign without ivermectin
- •Joe’s question: why ivermectin drew disproportionate backlash
- •Malone’s framing: off-patent drug perceived as a business/policy threat
- 22:39 – 34:31
Mass formation and the ‘psywar’ lens: from Desmet’s theory to digital-era manipulation
Malone explains mass formation theory (as popularized by Mattias Desmet) as a vulnerability created by social disconnection and fear. He broadens this into a view that modern behavioral science, algorithmic amplification, and state-linked messaging form a new kind of psychological warfare environment.
- •Core mechanism: social isolation → vulnerability → attachment to leaders/narratives
- •Connections to historical totalitarian dynamics and crowd psychology
- •Modern tools: ‘nudge’ methods, targeted messaging, algorithmic control
- •Claim that these techniques migrated from military contexts to domestic policy
- 34:31 – 1:02:18
Censorship-by-ecosystem: Coca-Cola, GARM, ad pressure, and the CDC ‘banner’ as a nudge tool
Malone lays out a specific story of how corporate advertising networks and public health institutions allegedly pressured Spotify after his earlier JRE appearance. He describes the ‘go to the CDC’ content warnings as an example of behavioral nudging embedded in platforms.
- •Alleged chain: corporate complaint → ad network pressure → platform action
- •Role attributed to GARM and advertising leverage
- •Content warnings/banners framed as ‘nudge technology’
- •Broader claim: intertwined media, corporate, and public health influence
- 1:02:18 – 1:09:23
The repurposed-drug battlefield: hydroxychloroquine, Zelenko, retracted studies, and Cochrane disputes
They revisit other suppressed COVID treatments, focusing on hydroxychloroquine’s rise and collapse in public discourse and the impact of high-profile publications. Malone also describes ivermectin meta-analysis controversy and shifting inclusion/exclusion of studies.
- •Zelenko’s protocol and outreach to the White House
- •Lancet paper with fabricated/nonexistent data and later retraction
- •Cochrane/UK meta-analysis controversies and study exclusion debates
- •Narrative framing: suppression plus reputational and institutional enforcement
- 1:09:23 – 1:21:17
Profit, power, and the COVID wealth transfer—plus the ‘safe and effective’ messaging machine
Joe and Malone connect COVID policies to incentives, arguing lockdowns and vaccine rollouts drove an unprecedented upward transfer of wealth. Malone criticizes institutional messaging, including Nobel Prize timing and claims made to promote public acceptance.
- •Lockdowns, stimulus, and small-business collapse as wealth-transfer accelerants
- •Public repetition of “millions of lives saved” and ‘safe and effective’ slogans
- •Nobel Prize rationale discussed as an influence lever
- •Money vs. control: competing explanations for policy behavior
- 1:21:17 – 1:30:15
Building an independent media livelihood: Substack, shadowbanning claims, and why audiences shifted
Malone explains how he pivoted to Substack after reputational and consulting damage, crediting Rogan’s model of persistence and direct-to-audience publishing. They also discuss declining trust in mainstream media and the ‘Trusted News Initiative’ framing of Rogan as a business-model threat.
- •Substack as a resilience strategy after ‘delegitimization’
- •Claims of algorithmic suppression (‘shadowbanned/small-roomed’)
- •TNI and legacy media’s fear of decentralized information ecosystems
- •Why young audiences—especially men—seek nontraditional voices
- 1:30:15 – 1:33:24
Inside government now: ACIP role, vaccine policy fights, and challenges to entrenched systems
Malone describes serving as a (unpaid) Special Government Employee on the CDC’s ACIP, including working groups and the political/legal pressures around vaccine policy. He and Joe discuss liability shields, the Vaccines for Children program, and why schedules and mandates are hard to roll back.
- •Malone’s ACIP vice chair role and working group responsibilities
- •AAP lawsuit against ACIP changes and broader ‘lawfare’ concerns
- •Liability protections, VFC purchasing, and guaranteed-market dynamics
- •Mandates downstream at states/schools and the persistence of policy momentum
- 1:33:24 – 1:57:35
Animal disease policy and ‘lab leak’ fears: bird flu culling, resistant breeding, and Spain’s swine fever case
The discussion shifts to outbreak management in agriculture: why mass culling persists, when it may or may not work, and alternatives like resistant breeding or environmental interventions. Malone also highlights a breaking story in Spain involving African swine fever and alleged risky research practices.
- •Critique of reflexive ‘kill the herd’ policy for avian influenza
- •Natural reservoirs (migratory birds) make eradication via culling unrealistic
- •Alternative ideas: resistant chicken cultivars, water/feed interventions (e.g., HOCl)
- •Spain: African swine fever, alleged lab-linked risks, and trade impacts (China)
- 1:57:35 – 2:23:55
Biotech acceleration, artificial womb debate, and the ethics of a ‘Gattaca’ future
Rogan and Malone explore how rapidly advancing biotech may outpace ethics and regulation, using artificial wombs and genetic selection as key examples. They connect these themes to broader concerns about transhumanism, organ procurement abuses, and societal incentives toward ‘convenience’ over human development.
- •Low-probability/high-impact risk framing after COVID
- •Artificial wombs as an emerging capability and ethical stress test
- •CRISPR, sequencing costs, and the pathway to genetic selection
- •Cultural references: Gattaca, organ harvesting allegations, and transhumanist narratives
- 2:23:55 – 2:33:22
From UAPs to microreactors: speculation about next-era physics—and closing reflections
The conversation briefly detours into UAP/UFO-related claims and the possibility of new high-energy physics enabling unusual propulsion or ‘transmedium’ behavior. They end by correcting misinformation about a viral artificial-womb video and closing on how the public’s openness to dissenting views has changed since 2021–2022.
- •UAP discussion: ‘transmedium’ reports and advanced-energy hypotheses
- •Microreactor/fusion future as a transformative energy storyline
- •On-air correction: viral artificial-womb ‘factory’ video not tied to a real company
- •Closing: why this episode may be received less hostilely than the prior one
